Express Scripts said “despite promises to limit price increases, drugmakers are trying to game the market by delaying generic competition, blocking access to safe and effective biosimilars, and coyly deferring – not cancelling – list-price increases. This is why our work to expand access and maximize value is more important now than ever”.
In 2015, Express Scripts, the largest PBM-only company in the U.S., reported a profit of more than $660 million, from sales exceeding $25 billion.
In 2017, pharmacy benefits giant Express Scripts saw its net income skyrocket by 33% year-over-year to $4.51 billion.
It assumes that provider payment will be reduced to Medicare levels, that negotiation with prescription drugmakers will generate significant savings, and that administrative costs will be cut from 13 to 6 percent.
Several pharmaceutical companies have recently said they’ll delay some of their price increases, under pressure from the Trump administration. But hospitals have made no such concessions, even though they make up a much larger share of total health care spending.
Pfizer, Novartis, Merck and other drug makers have said they will delay, freeze or roll back price increases on some of their medicines. Experts largely dismissed those pledges as political bandages with little real effect on patients’ pocketbooks.
The biggest threats to our health care is not the cost of prescription drugs.
The health insurance industry is tracking your race, education level, TV habits, marital status, net worth. They’re collecting what you post on social media, whether you’re behind on your bills, what you order online. Then they feed this information into complicated computer algorithms that spit out predictions about how much your health care could cost them.
Medical experts say that digital health can’t do much for users that are already sick, or at high risk of a serious medical condition. Many of these companies won’t diagnose disease for regulatory reasons, even if they’re picking up strong signals through sensors and algorithms, so instead they’ll suggest that a user see their doctor.
Population levels of physical activity, inadequate to meet current guidelines can place a health burden on the U.S. population that results in higher health care expenditures.
Regular physical activity is associated with important health benefits, including reduced risk for premature death, cardiovascular disease, ischemic stroke, type 2 diabetes, colon and breast cancers, and depression.
A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that.